These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 27634334)

  • 1. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
    Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
    Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA replication stress: a source of APOBEC3B expression in breast cancer.
    Cescon DW; Haibe-Kains B
    Genome Biol; 2016 Sep; 17(1):202. PubMed ID: 27716362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
    Roelofs PA; Martens JWM; Harris RS; Span PN
    Clin Cancer Res; 2023 May; 29(9):1658-1669. PubMed ID: 36478188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of APOBEC3 Exacerbates DNA Replication Stress and Chromosomal Instability in Early Breast and Lung Cancer Evolution.
    Venkatesan S; Angelova M; Puttick C; Zhai H; Caswell DR; Lu WT; Dietzen M; Galanos P; Evangelou K; Bellelli R; Lim EL; Watkins TBK; Rowan A; Teixeira VH; Zhao Y; Chen H; Ngo B; Zalmas LP; Al Bakir M; Hobor S; Grönroos E; Pennycuick A; Nigro E; Campbell BB; Brown WL; Akarca AU; Marafioti T; Wu MY; Howell M; Boulton SJ; Bertoli C; Fenton TR; de Bruin RAM; Maya-Mendoza A; Santoni-Rugiu E; Hynds RE; Gorgoulis VG; Jamal-Hanjani M; McGranahan N; Harris RS; Janes SM; Bartkova J; Bakhoum SF; Bartek J; Kanu N; Swanton C;
    Cancer Discov; 2021 Oct; 11(10):2456-2473. PubMed ID: 33947663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
    Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
    Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
    Bonvin M; Greeve J
    Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism and clinical impact of APOBEC3B-catalyzed mutagenesis in breast cancer.
    Harris RS
    Breast Cancer Res; 2015 Jan; 17(1):8. PubMed ID: 25848704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3-mediated restriction of RNA virus replication.
    Milewska A; Kindler E; Vkovski P; Zeglen S; Ochman M; Thiel V; Rajfur Z; Pyrc K
    Sci Rep; 2018 Apr; 8(1):5960. PubMed ID: 29654310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
    Nowarski R; Kotler M
    Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosine Deaminase APOBEC3A Sensitizes Leukemia Cells to Inhibition of the DNA Replication Checkpoint.
    Green AM; Budagyan K; Hayer KE; Reed MA; Savani MR; Wertheim GB; Weitzman MD
    Cancer Res; 2017 Sep; 77(17):4579-4588. PubMed ID: 28655787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytidine deaminase APOBEC3C has unique sequence and genome feature preferences.
    Brown GW
    Genetics; 2024 Aug; 227(4):. PubMed ID: 38946641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition.
    Buisson R; Lawrence MS; Benes CH; Zou L
    Cancer Res; 2017 Sep; 77(17):4567-4578. PubMed ID: 28698210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APOBEC3A damages the cellular genome during DNA replication.
    Green AM; Landry S; Budagyan K; Avgousti DC; Shalhout S; Bhagwat AS; Weitzman MD
    Cell Cycle; 2016; 15(7):998-1008. PubMed ID: 26918916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.
    Ng JCF; Quist J; Grigoriadis A; Malim MH; Fraternali F
    Nucleic Acids Res; 2019 Feb; 47(3):1178-1194. PubMed ID: 30624727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
    Adolph MB; Love RP; Feng Y; Chelico L
    Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of DNA cytosine deaminase APOBEC3 proteins, a potential source for producing mutations, in gastric, colorectal and prostate cancers.
    Gwak M; Choi YJ; Yoo NJ; Lee S
    Tumori; 2014; 100(4):112e-7e. PubMed ID: 25296601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
    Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
    PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells.
    Nikkilä J; Kumar R; Campbell J; Brandsma I; Pemberton HN; Wallberg F; Nagy K; Scheer I; Vertessy BG; Serebrenik AA; Monni V; Harris RS; Pettitt SJ; Ashworth A; Lord CJ
    Br J Cancer; 2017 Jun; 117(1):113-123. PubMed ID: 28535155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of APOBEC3 Proteins and Catalytic Activity in Urothelial Carcinoma.
    Jaguva Vasudevan AA; Goering W; Häussinger D; Münk C
    Methods Mol Biol; 2018; 1655():97-107. PubMed ID: 28889380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.